Nexalin Technology (NXL) news

Trading released/resumed: (NXL) Reason not available

Nexalin Technology (NXL) has experienced a significant decline in its market capitalization, currently standing at $5.38 million as of October 1, 2026, representing a -66.30% decrease over the past year . Since its initial public offering on September 16, 2022, the company's market cap has dropped…

Trading released/resumed: (NXL) Reason not available

Trading in shares of Nexalin Technology, Inc. (NXL) has resumed following a prior suspension, though the specific reason for the halt has not been disclosed by the company or relevant regulatory authorities. Investors are advised to monitor official announcements for further clarification on the…

Trading halted: (NXL) Due to limit-up limit-down trading pause

Trading in shares of Nexalin Technology, Inc. (NXL) has been temporarily suspended due to a limit-up limit-down trading pause. This halt is typically implemented by exchanges to prevent excessive volatility and to allow for orderly trading conditions when a stock experiences significant price…

Nexalin Tech: Reverse stock split

Nexalin: Nexalin & Greenlight have entered into a partnership

Nexalin Technology, Inc. (Nasdaq: NXL) has not entered into a partnership with Greenlight Financial Technology, Inc. as of May 19, 2026. Instead, Nexalin continues to focus on its development of non-invasive neurostimulation devices for the treatment of mental health and cognitive disorders,…